These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29018067)

  • 21. Introducing misoprostol for the treatment of incomplete abortion in Nigeria.
    Dah T; Akiode A; Awah P; Fetters T; Okoh M; Ujah I; Oji E
    Afr J Reprod Health; 2011 Dec; 15(4):42-50. PubMed ID: 22571104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment with misoprostol by midwives is safe and effective.
    Badawy AM; Elnashar AM
    Lancet; 2015 Jun; 385(9985):2335-7. PubMed ID: 25817471
    [No Abstract]   [Full Text] [Related]  

  • 23. Early termination of pregnancy by single-dose 800 microg misoprostol compared with surgical evacuation.
    Prasad S; Kumar A; Divya A
    Fertil Steril; 2009 Jan; 91(1):28-31. PubMed ID: 18295212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicians' approaches to post-abortion care in Manila, Philippines.
    Cansino C; Melgar JL; Burke A
    Int J Gynaecol Obstet; 2010 Jun; 109(3):216-8. PubMed ID: 20176351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study between oral and sublingual 600 µg misoprostol for the treatment of incomplete abortion.
    Paritakul P; Phupong V
    J Obstet Gynaecol Res; 2010 Oct; 36(5):978-83. PubMed ID: 20846257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perceptions of misoprostol among providers and women seeking post-abortion care in Zimbabwe.
    Maternowska MC; Mashu A; Moyo P; Withers M; Chipato T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):16-25. PubMed ID: 25702065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting.
    Ngoc NT; Shochet T; Blum J; Hai PT; Dung DL; Nhan TT; Winikoff B
    BMC Pregnancy Childbirth; 2013 May; 13():118. PubMed ID: 23697561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania.
    Shwekerela B; Kalumuna R; Kipingili R; Mashaka N; Westheimer E; Clark W; Winikoff B
    BJOG; 2007 Nov; 114(11):1363-7. PubMed ID: 17803714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana.
    Taylor J; Diop A; Blum J; Dolo O; Winikoff B
    Int J Gynaecol Obstet; 2011 Jan; 112(1):40-4. PubMed ID: 21122848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries.
    Shochet T; Diop A; Gaye A; Nayama M; Sall AB; Bukola F; Blandine T; Abiola OM; Dao B; Olayinka O; Winikoff B
    BMC Pregnancy Childbirth; 2012 Nov; 12():127. PubMed ID: 23150927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion.
    Weeks A; Alia G; Blum J; Winikoff B; Ekwaru P; Durocher J; Mirembe F
    Obstet Gynecol; 2005 Sep; 106(3):540-7. PubMed ID: 16135584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outpatient versus inpatient intravaginal misoprostol for the treatment of first trimester incomplete miscarriage: a randomised controlled trial.
    Ng BK; Annamalai R; Lim PS; Aqmar Suraya S; Nur Azurah AG; Muhammad Abdul Jamil MY
    Arch Gynecol Obstet; 2015 Jan; 291(1):105-13. PubMed ID: 25078052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misoprostol versus manual vacuum aspiration for treatment of first-trimester incomplete miscarriage in a low-resource setting: A randomized controlled trial.
    Nwafor JI; Agwu UM; Egbuji CC; Ekwedigwe KC
    Niger J Clin Pract; 2020 May; 23(5):638-646. PubMed ID: 32367870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a training intervention in increasing the use of misoprostol in postabortion care in Malawi: a quasi-experimental study.
    Magreta Chakhame B; Darj E; Mwapasa M; Kafulafula U; Chiudzu G; Maluwa A; Malata A; Odland JØ; Odland ML
    BMJ Open; 2022 Dec; 12(12):e061886. PubMed ID: 36517095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An approach to evaluate the efficacy of vaginal misoprostol administered for a rapid management of first trimester spontaneous onset incomplete abortion, in comparison to surgical curettage.
    Patua B; Dasgupta M; Bhattacharyya SK; Bhattacharya S; Hasan SH; Saha S
    Arch Gynecol Obstet; 2013 Dec; 288(6):1243-8. PubMed ID: 23708389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
    Andersson IM; Benson L; Christensson K; Gemzell-Danielsson K
    Hum Reprod; 2016 Jan; 31(1):67-74. PubMed ID: 26573530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.
    Lemmers M; Verschoor MAC; Bossuyt PM; Huirne JAF; Spinder T; Nieboer TE; Bongers MY; Janssen IAH; Van Hooff MHA; Mol BWJ; Ankum WM; Bosmans JE;
    Acta Obstet Gynecol Scand; 2018 Mar; 97(3):294-300. PubMed ID: 29266169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral misoprostol for the management of incomplete abortion in Ecuador.
    Montesinos R; Durocher J; León W; Arellano M; Peña M; Pinto E; Winikoff B
    Int J Gynaecol Obstet; 2011 Nov; 115(2):135-9. PubMed ID: 21872244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.